drugset / Trial / NCT00003147
Gene Therapy in Treating Patients With Cancer of The Liver
NaSingle-groupOpen-labelTreatment
Summary
Phase I trial to study the effectiveness of gene therapy with the p53 gene in treating patients who have cancer of the liver that cannot be surgically removed. Inserting the p53 gene into a person's tumor may improve the body's ability to fight liver cancer.
Timeline
- Start
- 1998-02
- Primary completion
- 2003-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CONTUSUGENE LADENOVEC | Unknown | — | Other |